All you need to know is this:
Ovanti’s survival does not rely on the IDSB sale.
It’s a bonus, not a lifeline. The U.S. BNPL license, strategic partnerships, and new leadership direction are the real play here. You’re obsessing over one piece of the puzzle while the bigger picture is already shifting.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.011M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $2.164K | 1.082M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 113 | 99707519 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 42155762 | 45 |
View Market Depth
| Last trade - 15.59pm 13/06/2025 (20 minute delay) ? |
| OVT (ASX) Chart |